Skip to main content

1Provenance card

the boundary, as counts

Sources

2620 with DOI

0 strong · 15 moderate · 11 weak

Compilations

12026-05-08T16:06:12.180Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

33last ruled 2026-06-04

0 awaiting a ruling

Issued documents

42026-10-19T20:30:51.335Z

notice · info card · emergency

Searches

141 with no results

queries and counts on the build

Claims checked

8164 supported

64 supported · 17 not

Correspondence

0received

consent field ships in Phase 4

Edges

248

derivations recorded for this entity

Complete over 26 sources, 1 compilation, and 33 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/bromazolam/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-10-02srcThe emergence of new psychoactive substance (NPS) benzodiazepines: A review.
  3. 2026-10-02srcChanging trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use
  4. 2026-10-02srcDetected substances among patients with confirmed bromazolam exposure who present to the emergency department following a suspected opioid and/or stimulant-related non-fatal overdose
  5. 2026-10-02srcChanging characteristics in the 2020s of fatal 'novel' benzodiazepine toxicity cases in Australia
  6. 2026-10-02srcPost mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales
  7. 2026-10-02srcOccult bromazolam exposure in patients presenting with opioid or stimulant overdose
  8. 2026-10-02srcClinical characterisation of the novel benzodiazepine bromazolam-data from the ASSIST (A Surveillance Study of Illicit Substance Toxicity) study
  9. 2026-10-02srcDetection of bromazolam alongside other misused substances
  10. 2026-10-02srcFlubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam
  11. 2026-10-02srcBromazolam Blood Concentrations in Postmortem Cases—A British Columbia Perspective
  12. 2026-10-02srcThe emergence of bromazolam in Jefferson County, AL: a case series
  13. 2026-10-02srcIdentifying bromazolam, etizolam, and flualprazolam in blood using gas chromatography-mass spectrometry
  14. 2026-10-02srcBenzodiazepine Co-Exposure Among Patients Presenting to the Emergency Department With a Confirmed Opioid Overdose
  15. 2026-10-02srcThe surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco
  16. 2026-10-02srcChanges over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia
  17. 2026-10-02srcSuccessful symptom-based management of active withdrawal from multiple illicit benzodiazepines
  18. 2026-10-02srcA Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model
  19. 2026-10-02srcNotes from the Field: Seizures, Hyperthermia, and Myocardial Injury in Three Young Adults Who Consumed Bromazolam Disguised as Alprazolam - Chicago, Illinois, February 2023
  20. 2026-10-02srcDesigner Benzodiazepines: A Review of Toxicology and Public Health Risks
  21. 2026-10-02srcPhenibut and Bromazolam Use Disorders Requiring Hospitalization for Medically Supervised Withdrawal
  22. 2026-10-02srcCouncil Decision (EU) 2024/832 - Scheduling under UN Convention on Psychotropic Substances
  23. 2026-10-02srcSchedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
  24. 2026-10-02srcWHO Expert Committee on Drug Dependence - 45th Meeting Critical Review Report: Bromazolam
  25. 2026-10-02srcWHO Expert Committee on Drug Dependence - 46th Meeting Critical Review Report: Bromazolam
  26. 2026-10-02srcThe Misuse of Drugs and Misuse of Drugs (Designation) (England and Wales and Scotland) (Amendment and Revocation) Regulations 2024
  27. 2026-10-02srcBromazolam — PubChem Compound Summary (CID 12562546)
  28. 2026-09-04issueIssued emergency
  29. 2026-09-04issueIssued info_card
  30. 2026-09-04issueIssued notice
  31. 2026-06-04proposal31 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  32. 2026-06-04publicationPublication — backfill
  33. 2026-05-08revisionRevision 1
  34. 2026-05-08absenceSearched ClinicalTrials.gov for "bromazolam" — no results
  35. 2026-05-08genGeneration — pipeline-v5 · with 2 morepipeline-v5
  36. 2026-05-08rungeneration run

The same entries, as forms: six forms.